Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 57, 5051-5059, November 15, 1997]
© 1997 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yih, L.-H.
Right arrow Articles by Lee, T.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yih, L.-H.
Right arrow Articles by Lee, T.-C.

Sodium Arsenite Disturbs Mitosis and Induces Chromosome Loss in Human Fibroblasts1

Ling-Huei Yih, I-Ching Ho and Te-Chang Lee2

Institute of Biomedical Sciences, Academic Sinica, Taipei 115 [L. H. Y., I. C. H., T-C. L.], and Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 107 [L. H. Y.], Taiwan, Republic of China

Arsenite, a unique human carcinogen, induces many types of cytogenetic alterations, such as sister chromatid exchanges, chromosome aberrations, and endoreduplication in a variety of in vivo and in vitro systems. Cytogenetic alterations are frequently associated with cancer development. The purpose of this study was to explore how arsenite induces cytogenetic alterations in human skin fibroblasts (HFW). The present results show that treatment of G2-enriched HFW cells with 5 µM arsenite results in significant delay of cell cycle progression, accumulation of mitotic cells, and prolongation of mitosis. Arsenite-induced G2 and mitotic delay are accompanied by accumulation of cyclin B1 and hyperphosphorylation of cdc2 and Mos proteins. In addition to mitotic delay and prolongation, arsenite treatment also induced out-of-phase centromere separation and alterations of chromosome segregation, such as the appearance of c-metaphase, ball-metaphase, and lagged chromosomes. Unlike spindle poisons, arsenite at the dose range used did not inhibit the spindle fiber formation but conceivably deranges the spindle apparatus. By analyzing the karyotype of established subclones surviving arsenite injury, 18% (8 of 44) showed one chromosome loss, whereas all 26 subclones derived from the untreated cultures were diploid. Furthermore, most arsenite-treated clones manifest prolonged life span (86 ± 18 population doublings) as compared to those derived from the untreated cultures (44 ± 11 population doublings). Unfortunately, none became immortal. Collectively, treatment of the G2-enriched HFW cells with arsenite can disturb the mitotic events and subsequently induce chromosome loss.

1 This work was supported by Academia Sinica and a grant from the National Science Council, Republic of China.

2 To whom requests for reprints should be addressed. Phone: 886-2-7899014; Fax: 886-2-7825573; E-mail: bmtcl@ibms.sinica.edu.tw.

Received 12/ 2/96. Accepted 9/19/97.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
B. F. Taylor, S. C. McNeely, H. L. Miller, G. M. Lehmann, M. J. McCabe Jr., and J. C. States
p53 Suppression of Arsenite-Induced Mitotic Catastrophe Is Mediated by p21CIP1/WAF1
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 142 - 151.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L. Holmes, S. S. Wise, S. J. Sandwick, W. L. Lingle, V. C. Negron, W. D. Thompson, and J. P. Wise Sr.
Chronic exposure to lead chromate causes centrosome abnormalities and aneuploidy in human lung cells.
Cancer Res., April 15, 2006; 66(8): 4041 - 4048.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J.-I Chao, S.-H. Hsu, and T.-C. Tsou
Depletion of Securin Increases Arsenite-Induced Chromosome Instability and Apoptosis via a p53-Independent Pathway
Toxicol. Sci., March 1, 2006; 90(1): 73 - 86.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-H. Yih, Y.-Y. Tseng, Y.-C. Wu, and T.-C. Lee
Induction of Centrosome Amplification during Arsenite-Induced Mitotic Arrest in CGL-2 Cells
Cancer Res., February 15, 2006; 66(4): 2098 - 2106.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
J.-P. Li, J.-C. Lin, and J.-L. Yang
ERK Activation in Arsenite-Treated G1-Enriched CL3 Cells Contributes to Survival, DNA Repair Inhibition, and Micronucleus Formation
Toxicol. Sci., January 1, 2006; 89(1): 164 - 172.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
P.-C. Lee, I-C. Ho, and T.-C. Lee
Oxidative Stress Mediates Sodium Arsenite-Induced Expression of Heme Oxygenase-1, Monocyte Chemoattractant Protein-1, and Interleukin-6 in Vascular Smooth Muscle Cells
Toxicol. Sci., May 1, 2005; 85(1): 541 - 550.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L.-H. Yih, S.-W. Hsueh, W.-S. Luu, T. H. Chiu, and T.-C. Lee
Arsenite induces prominent mitotic arrest via inhibition of G2 checkpoint activation in CGL-2 cells
Carcinogenesis, January 1, 2005; 26(1): 53 - 63.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L.-H. Yih and T.-C. Lee
Induction of C-Anaphase and Diplochromosome through Dysregulation of Spindle Assembly Checkpoint by Sodium Arsenite in Human Fibroblasts
Cancer Res., October 15, 2003; 63(20): 6680 - 6688.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
L.-H. Yih, K. Peck, and T.-C. Lee
Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment
Carcinogenesis, May 1, 2002; 23(5): 867 - 876.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. J. McCabe Jr., K. P. Singh, S. A. Reddy, B. Chelladurai, J. G. Pounds, J. J. Reiners Jr., and J. C. States
Sensitivity of Myelomonocytic Leukemia Cells to Arsenite-Induced Cell Cycle Disruption, Apoptosis, and Enhanced Differentiation Is Dependent on the Inter-Relationship between Arsenic Concentration, Duration of Treatment, and Cell Cycle Phase
J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 724 - 733.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
L.-H. Yih and T.-C. Lee
Arsenite Induces p53 Accumulation through an ATM-dependent Pathway in Human Fibroblasts
Cancer Res., November 1, 2000; 60(22): 6346 - 6352.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
M. P. Waalkes, D. A. Fox, J. C. States, S. R. Patierno, and M. J. McCabe Jr.
Metals and Disorders of Cell Accumulation: Modulation of Apoptosis and Cell Proliferation
Toxicol. Sci., August 1, 2000; 56(2): 255 - 261.
[Full Text] [PDF]


Home page
CarcinogenesisHome page
R. C.-T. Yu, T.-C. Lee, T.C. Wang, and J.-H. Li
Genetic toxicity of cocaine
Carcinogenesis, July 1, 1999; 20(7): 1193 - 1199.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. X. Liu, M. Athar, I. Lippai, C. Waldren, and T. K. Hei
Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity
PNAS, February 13, 2001; 98(4): 1643 - 1648.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1997 by the American Association for Cancer Research.